Health News (Reuters)

China to accept overseas trial data in bid to speed up drug approvals

SHANGHAI (Reuters) - China said it plans to accept data from overseas clinical trials to speed up approvals of drugs, a potential boon for international drugmakers as well as patients who often face lengthy delays for new medicines to reach the market.

Drug chains tumble on reports Amazon eyeing their pie

(Reuters) - Shares of drug retailers Walgreens Boots Alliance Inc , CVS Health Corp and Rite Aid Corp tumbled on Friday after reports that Inc was looking to make a move into selling drugs online.

Flexion's knee pain drug gets FDA nod, shares hit life high

(Reuters) - Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday.

Trump undermines U.S. birth control coverage requirement

WASHINGTON/NEW YORK (Reuters) - President Donald Trump's administration on Friday undermined requirements under the Obamacare law that employers provide insurance to cover women's birth control, keeping a campaign pledge that pleased his conservative Christian supporters.

Weight loss surgery linked to lower risk of cancer

(Reuters Health) - Severely obese people who undergo surgery to shed excess pounds may have lower odds of developing cancer than they would without the operations, a recent U.S. study suggests.

In Puerto Rico, lives depend on volunteer doctors and diesel generators

OROCOVIS, Puerto Rico (Reuters) - At a community center in Orocovis, an isolated agricultural town of 23,000 in the mountains of central Puerto Rico, six oxygen-dependent patients drew breath with the help of the diesel generator powering their equipment.

Bayer says Phase III Xarelto study halted early

BERLIN (Reuters) - Bayer and partner Johnson & Johnson suffered a setback for blockbuster clot prevention drug Xarelto, with the German company saying a Phase III study had been halted early after the drug showed no efficacy improvements over low-dose aspirin.

Cash injection: sovereign funds target healthcare

LONDON (Reuters) - Imagine contact lenses that monitor glucose levels for diabetics, tiny implants to tackle chronic diseases, or algorithms that crunch data to predict illness rates.

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement.

Teva's Copaxone faces generic competition in Europe after U.S. hit

LONDON (Reuters) - Teva's blockbuster multiple sclerosis treatment Copaxone will face additional generic competition in Europe, just two days after Mylan NV won U.S. approval to sell cheaper versions of the medicine in the world's largest market.

New Jersey sues Insys as opioid maker settles with Massachusetts

BOSTON (Reuters) - New Jersey on Thursday accused Insys Therapeutics Inc of engaging in a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations.